Description: Chengdu Easton Biopharmaceuticals Co., Ltd. engages in the research, development, manufacture, and commercialization of pharmaceutical products. The company provides finished dosage forms in anesthetic/analgesics, cardiovascular, oncology, pediatrics, and other therapeutic fields. It also offers active pharmaceutical ingredients in oncology, cardiovascular, anesthetic/analgesics, anti-inflammatory, gastrointestinal, antiemetic, neurology/psychiatry , and urinary system therapeutic categories. The company was founded in 2009 and is based in Chengdu, China.
Home Page: www.eastonpharma.cn
No.8, Xiyuan Avenue
Chengdu,
611731
China
Phone:
86 28 6758 5121
Officers
| Name | Title |
|---|---|
| Mr. Mingxu Yuan | GM & Director |
| Mr. Changjian Xiong | CFO & Director |
| Mr. Zenggui Chen | Deputy MG & Director |
| Mr. Daming Zhang | Deputy GM & Director |
| Mr. Xiao Xun Li | Chief Scientist of APIs & Core Technician |
| Mr. Avinash Ramkisan Mane | Chief Scientist of Formulation Research Department & Core Technician |
| Mr. Yiou Wang | Board Sec. |
| Mr. Tian Rong Lin | Deputy GM & Core Technician |
| Mr. Hong Chen | Deputy GM & Core Technician |
| Mr. Zheng Pin Guan | Deputy GM & Core Technician |
Exchange: SHG
Country: CN
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 29.9406 |
| Price-to-Book MRQ: | 2.8232 |
| Price-to-Sales TTM: | 6.2741 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 1188 |